
Gamma-Aminobutyric Acid (GABA) Powder is a fermentation-derived ingredient supplied at NLT 98.0% on a dry basis. Identified by CAS 56-12-2, this typically carrier-free crystalline powder is suitable for capsules, tablets, stick packs, beverage powders and gummies. Standard 60–100 mesh grades, HPLC verification, batch-specific quality documentation and 25 kg commercial packaging support formulation development and bulk procurement.
| Parameter | Specification |
|---|
| Product Name | Gamma-Aminobutyric Acid (GABA) Powder |
| Other Names | GABA; gamma-aminobutyric acid |
| Chemical Name | 4-Aminobutanoic acid |
| CAS Number | 56-12-2 |
| Molecular Formula | C₄H₉NO₂ |
| Molecular Weight | 103.12 g/mol |
| Manufacturing Process | Fermentation, filtration, purification, crystallization, drying and sieving |
| Specification | GABA NLT 98.0% on a dry basis |
| Analytical Method | HPLC |
| Grade | Food or dietary supplement applications, subject to destination-market requirements |
| Carrier | Typically carrier-free; confirm the supplied grade |
| Appearance | White to off-white crystalline powder |
| Odor and Taste | Low odor; characteristic taste |
| Particle Size | Typically 60–100 mesh |
| Loss on Drying | Typically NMT 1.0% |
| Water Activity | Project-specific |
| Powder Handling | Bulk density, tapped density and flow characteristics available for application evaluation |
| pH | Determined using an agreed solution concentration and analytical method |
| Solubility | Water-soluble at practical formulation levels; verify in the finished matrix |
| Related Substances | HPLC profile or project-specific limits |
| Safety Testing | Heavy-metal and microbiological limits defined in the applicable COA |
| Packaging | Typically 25 kg per fiber drum or carton |
| Shelf Life | Typically 24 months under recommended storage conditions |
| Storage | Store sealed in a cool, dry environment |
| Origin | Confirm against applicable batch documentation |
| Parameter | Specification |
|---|---|
| Product Name | Gamma-Aminobutyric Acid (GABA) Powder |
| Other Names | GABA; gamma-aminobutyric acid |
| Chemical Name | 4-Aminobutanoic acid |
| CAS Number | 56-12-2 |
| Molecular Formula | C₄H₉NO₂ |
| Molecular Weight | 103.12 g/mol |
| Manufacturing Process | Fermentation, filtration, purification, crystallization, drying and sieving |
| Specification | GABA NLT 98.0% on a dry basis |
| Analytical Method | HPLC |
| Grade | Food or dietary supplement applications, subject to destination-market requirements |
| Carrier | Typically carrier-free; confirm the supplied grade |
| Appearance | White to off-white crystalline powder |
| Odor and Taste | Low odor; characteristic taste |
| Particle Size | Typically 60–100 mesh |
| Loss on Drying | Typically NMT 1.0% |
| Water Activity | Project-specific |
| Powder Handling | Bulk density, tapped density and flow characteristics available for application evaluation |
| pH | Determined using an agreed solution concentration and analytical method |
| Solubility | Water-soluble at practical formulation levels; verify in the finished matrix |
| Related Substances | HPLC profile or project-specific limits |
| Safety Testing | Heavy-metal and microbiological limits defined in the applicable COA |
| Packaging | Typically 25 kg per fiber drum or carton |
| Shelf Life | Typically 24 months under recommended storage conditions |
| Storage | Store sealed in a cool, dry environment |
| Origin | Confirm against applicable batch documentation |
| Documents and Declarations | COA, TDS, SDS and applicable allergen, GMO, gluten, dietary, irradiation or origin information |
| Test Item | Typical Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | Conforms by HPLC retention time; FTIR available when agreed |
| GABA Assay | NLT 98.0% on a dry basis |
| Particle Size | Typically 60–100 mesh |
| Loss on Drying | NMT 1.0% |
| Related Substances | HPLC profile or agreed project-specific limits |
| Carrier Status | Confirmed against the supplied grade |
| Water Activity | Project-specific testing |
| Bulk / Tapped Density | Available for application qualification |
| Lead | NMT 0.5 ppm |
| Arsenic | NMT 1.0 ppm |
| Cadmium | NMT 1.0 ppm |
| Mercury | NMT 0.1 ppm |
| Total Heavy Metals | NMT 10 ppm |
| Total Plate Count | NMT 1,000 CFU/g |
| Yeast and Mold | NMT 100 CFU/g |
| Coliforms | NMT 10 CFU/g |
| Escherichia coli | Negative in 10 g |
| Salmonella | Negative in 25 g |
Product qualification should begin by matching the ingredient name, CAS number, quoted grade and batch COA with the approved purchasing specification. Confirm that the GABA assay is reported on a dry basis and that HPLC identity and quantitative results apply to the same production batch. Carrier status requires separate verification because a typically carrier-free standard grade differs from a customized premix. Particle size, related substances, water activity and powder density may require additional review when filling performance, blend uniformity or process stability is important. Loss on drying should not automatically be interpreted as a direct measurement of water content without an appropriate analytical basis. Individual heavy-metal limits and microbiological results should be checked against the intended application and destination-market requirements. Beverage and gummy projects may also require documented compatibility testing under representative processing conditions. Review applicable allergen, dietary and origin declarations where relevant. Final material release should reflect the agreed specification, batch traceability, packaging configuration and any additional project-specific acceptance criteria.
| Application | Formulation Consideration |
|---|---|
| Capsules | Evaluate particle size, powder flow and fill-weight consistency. |
| Tablets | Assess blend uniformity, excipient compatibility and compression behavior. |
| Stick Packs | Control powder segregation, serving consistency and moisture exposure. |
| Powder Blends | Confirm ingredient compatibility, dispersion and finished-product assay targets. |
| Beverage Powders and RTD Concepts | Evaluate dissolution, taste, matrix compatibility and processing stability. |
| Gummies | Assess mixing sequence, heat exposure and distribution within the finished matrix. |
Formulation development should begin with the intended delivery format because powder handling and ingredient behavior differ across capsules, beverages and gummies. Dry applications require attention to particle-size distribution, powder flow, blend uniformity and filling consistency. Beverage systems should be evaluated for dissolution, taste, solution appearance and compatibility with other formulation components. Gummy applications require additional consideration of mixing sequence, processing temperature and distribution throughout the finished matrix. Inclusion levels should be based on the intended finished-product target, verified batch assay and destination-market requirements rather than generalized consumer dosage assumptions. When GABA is combined with other amino acids, assess ingredient declarations, sensory interactions and finished-product stability before production. Relevant formulation concepts can be explored through Sleep, Stress & Mood Solutions. For broader ingredient background, consult the GABA ingredient guide. Final processing decisions should be supported by representative production trials, documented compatibility checks and approved quality-release criteria for the intended finished product.
| Item | Details |
|---|---|
| Commercial Packaging | Typically 25 kg per fiber drum or carton. |
| Inner Packaging | PE or foil liner according to the agreed packaging configuration. |
| Shelf Life | Typically 24 months under recommended storage conditions. |
| Storage Conditions | Store sealed in a cool, dry location away from excessive heat and humidity. |
| Handling | Reseal promptly after opening and minimize unnecessary moisture exposure. |
| Shipping | Arranged according to order quantity, destination and packaging requirements. |
| Export Documentation | Commercial and technical documents supplied according to agreed order requirements. |
| Item | Details |
|---|---|
| Qualification Samples | 100 g, 500 g or 1 kg, subject to availability. |
| Pilot Quantities | Typically 1–5 kg for formulation trials. |
| Standard Commercial Quantity | Typically 25 kg per fiber drum or carton. |
| Typical Lead Time | Commonly 7–15 working days, subject to availability. |
| Technical Documents | COA, TDS, SDS and current product specification. |
| Additional Declarations | Applicable allergen, GMO, gluten, dietary, irradiation or origin information. |
| Project Requirements | Confirm grade, carrier status, particle size, packaging and required testing. |
| Inquiry Information | Include destination market, intended application, quantity and documentation needs. |
Request a qualification sample, current specification, batch COA and 25 kg bulk quotation.
Share your target specification, application, quantity and document needs. We will help confirm suitable options, COA/TDS/SDS support and bulk supply details.
Explore related ingredients for formula comparison, complementary applications and alternative sourcing options across food, beverage, supplement and wellness projects.